Leaders Free III: BioFreedom™ Clinical Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 404 participants.

Also called NCT03118895

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 404 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03118895
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France, Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03118895. Allocation not applicable; no masking; primary purpose treatment. Start 2017-11-08 (actual); primary completion 2019-09-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Leaders Free III: BioFreedom™ Clinical Trial
Condition
Cardiac Death
Condition
Stent Thrombosis
Condition
Bleeding
Condition
Mortality
Intervention (Device)
BioFreedom™ BA9™ drug-coated stent
Lead sponsor
Biosensors Europe SA (class: industry)
Collaborator
European Cardiovascular Research Center (class: research network)

Record details

Record id
cardio:ct-nct03118895
Content hash
3d6c61d2e0adc310946edcb364de9b9555b9d16ca4849cc2439d8ac8f8181cb9